Rejected at 11:16 p.m. Jun, 03, 2024 ] by Cameron
Bulk Suggestion Bulk ID: siam.med/06.03.24-05:37AM
Author: siam.med
Related Note: 1474059954350
Rationale for change

This image shows the pathophysiology of HIT and it is put in another note ( NID 1474059951940 )
and these 2 notes are also related .

Rejection reason

Trying my best to ignore, will discard to make it easier :)

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::17_Platelet_disorders::*Heparin_Induced_Thrombocytopenia #AK_Step2_v12::#AMBOSS::7T04H2 #AK_Other::AnKing_Image::!Subjects::Hematology_&_Oncology::Heparin_Induced_Thrombocytopenia #AK_Step1_v12::#AMBOSS::z4arNk #AK_Step1_v12::#UWorld::Step::15120 #AK_Step2_v12::#AMBOSS::uT0ps2 #AK_Step2_v12::#CMS::Surgery::Form_06 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::03_Heparin_(MOA,_Indications,_ADR,_CI) #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#Pathoma::04_Hemostasis::03_Other_Disorders_of_Hemostasis #AK_Step2_v12::#AMBOSS::Bx0zAR #AK_Step2_v12::#FirstAid::07_Hematology::02_Hypercoagulable_States::03_Heparin-Induced_Thrombocytopenia_(HIT) #AK_Step2_v12::#UWorld::COMLEX::101730 #PANCE::HEME::coagulation_disorders #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::AnKing_Image::AhmedA::Heparin_Induced_Thrombocytopenia #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#UWorld::Step::6993 #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::19_Platelet_Disorders #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::18_Coagulopathy #AK_Step1_v12::#AMBOSS::OB0Iai #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::03_HIT_DIC_Disorders_of_Fibrinolysis #AK_Step1_v12::#NBME::18 #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step1_v12::#NBME::20 #AK_Step1_v12::#UWorld::COMLEX::26114 #AK_Step3_v12::#UWorld::5292 #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Other::Only_Step_1&2_Overlap #AK_Other::AnKing_Image::!Subjects::Hematology_&_Oncology #AK_Other::AnKing_Image::!Subjects::Hematology_and_Oncology::Heparin_Induced_Thrombocytopenia #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::17_Hypercoagulable_States